WASHINGTON, Jan. 29, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that members of its management team will participate in the Canaccord Genuity Rare Disease, Biopharma One-on-One Day on Tuesday, February 3, 2015 in New York, NY.
For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.
Investor Contact:
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-participate-in-the-canaccord-genuity-rare-disease-biopharma-one-on-one-day-300028196.html
SOURCE Vanda Pharmaceuticals Inc.
Help employers find you! Check out all the jobs and post your resume.
